Status
Conditions
Treatments
About
This study evaluates the effect of telemedicine intervention program upon glycemic control in type 1 diabetes mellitus children and their parents in Israel. Half of the participants will receive the telemedicine intervention for a period of six months while the other half will receive the regular treatment then vice versa. Each group will receive in the intervention period 6 telemedicine meeting with a dietician and six telemedicine meetings with a nurse.
The investigators hypothesized that the participants that are recieving the telemedicine intervention will have a better glycemic control after 6 months.
Full description
The prevalence of type 1 diabetes has been steadily increasing for the past few decades and is a relatively common chronic disease of childhood (1). Managing type 1 diabetes in young children presents unique challenges to the patient, parents, and to the pediatric health care provider. The diabetes regimen includes intensive blood glucose monitoring, multiple daily injections of insulin ,and frequent insulin dose adjustments according to the amount of carbohydrate eaten, blood sugar, and physical activity. The Diabetes Control and Complications Trail (DCCT) showed a significant link between blood glucose control and a slower onset and progression of diabetes complications, with improved glycemic control decreasing the risk of micro- and macro- vascular complication (2,3,4).
Glycosylated hemoglobin A1c (HbA1c) measures the
In the past decade a significant progress took place in therapy and treatment of diabetes. However poor glycemic control is recorded in a significant proportion of adolescents.
Telehealthcare is the use of telecommunications to deliver healthcare services and involves the remote interaction between a primary care provider and specialist. Telemedicine represents a useful and cost-effective solution to the strict follow-up required in diabetes management ,
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
diagnosed with typ1 1 diabetes for at least 6 months insulin dependent participants provided consent to participate in the study consent to use the Accu-Chek Connect diabetes management app -
Exclusion criteria
new onset of diabetes type 1 not specified as type 1 diabetes
Primary purpose
Allocation
Interventional model
Masking
75 participants in 2 patient groups
Loading...
Central trial contact
Neriya Levran, RD; Zohar Landau, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal